Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache

PHASE3TerminatedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

April 1, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Pain
Interventions
DRUG

Paracetamol and Caffeine

Caplets containing 500 milligrams (mg) of paracetamol and 65 mg of caffeine

DRUG

Ibuprofen

Caplets containing 200 mg of ibuprofen

OTHER

Placebo

Matching placebo caplets

Trial Locations (1)

02451

PAREXEL International, LLC, Waltham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01842633 - Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache | Biotech Hunter | Biotech Hunter